Treatment advances in rheumatoid arthritis.
作者信息
Arriola E R, Lee N P
机构信息
UCLA Medical Center, Department of Pharmaceutical Services 90095, USA.
出版信息
West J Med. 1999 May;170(5):278-81.
Abstract
摘要
相似文献
1
Treatment advances in rheumatoid arthritis.
West J Med. 1999 May;170(5):278-81.
2
Rheumatoid arthritis. New disease-modifying and anti-inflammatory drugs.
Geriatrics. 2000 Mar;55(3):30-2, 35-6, 39-40.
3
Current concepts regarding pharmacologic treatment of rheumatoid and osteoarthritis.
Hand Clin. 2001 May;17(2):321-38, xi.
4
Rheumatoid arthritis drugs show promise.
Mayo Clin Health Lett. 1999 Jan;17(1):4.
5
New drugs for rheumatoid arthritis.
Med Lett Drugs Ther. 1998 Nov 20;40(1040):110-2.
6
New treatments for rheumatoid arthritis.
Health News. 1998 Nov 20;4(14):3.
7
I have rheumatoid arthritis and have been taking methotrexate. I'm interested in the new drugs that have been in the news lately. Just how effective are they?
Harv Womens Health Watch. 1999 Feb;6(6):8.
8
What's new in the diagnosis and treatment of juvenile rheumatoid arthritis.
J Pediatr Orthop. 2000 Jul-Aug;20(4):419-20.
9
Etanercept (Enbrel) -- an update.
Skin Therapy Lett. 2004;9(10):1-4, 9.
10
Celecoxib for rheumatoid arthritis.
J Fam Pract. 2000 Feb;49(2):108-9.
引用本文的文献
1
Leflunomide: a review of its use in active rheumatoid arthritis.
Drugs. 1999 Dec;58(6):1137-64. doi: 10.2165/00003495-199958060-00010.
本文引用的文献
1
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.
Lancet. 1999 Jan 23;353(9149):259-66. doi: 10.1016/s0140-6736(98)09403-3.
2
A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.
N Engl J Med. 1999 Jan 28;340(4):253-9. doi: 10.1056/NEJM199901283400401.
3
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects.
Arthritis Rheum. 1998 Sep;41(9):1591-602. doi: 10.1002/1529-0131(199809)41:9<1591::AID-ART9>3.0.CO;2-J.
4
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
Arthritis Rheum. 1998 Sep;41(9):1552-63. doi: 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W.
5
New insights in the pathogenesis of rheumatoid arthritis.
J Rheumatol Suppl. 1998 Jul;53:3-7.
6
Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.
N Engl J Med. 1997 Jul 17;337(3):141-7. doi: 10.1056/NEJM199707173370301.
7
The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase.
Biochemistry. 1996 Jan 30;35(4):1270-3. doi: 10.1021/bi952168g.
8
Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.
Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11693-7. doi: 10.1073/pnas.90.24.11693.
9
Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.
Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12013-7. doi: 10.1073/pnas.91.25.12013.
10
Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years.
Arthritis Rheum. 1984 Aug;27(8):864-72. doi: 10.1002/art.1780270805.
Zotero 插件